WELLINGTON-ALTUS USA INC.’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$199K Buy
2,294
+351
+18% +$28.3K 0.14% 121
2026
Q1
$152K Sell
1,943
-355
-15% -$34K 0.09% 187
2025
Q4
$221K Buy
+2,298
New +$223K 0.16% 105

Other funds holding MDT

WELLINGTON-ALTUS USA INC.'s MDT Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. increased its Medtronic (MDT) stake by 18% in Q2 2026, buying an estimated $28.3K and bringing the position to 2,294 shares worth $199K. The position accounts for 0.14% of the portfolio, ranked #121.

WELLINGTON-ALTUS USA INC. first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $221K in Q4 2025. 2,141 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • WELLINGTON-ALTUS USA INC. held 2,294 shares of Medtronic worth $199K as of Q2 2026.
  • WELLINGTON-ALTUS USA INC. bought 351 Medtronic shares in Q2 2026, an estimated $28.3K.
  • Medtronic made up 0.14% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #121 holding.
  • WELLINGTON-ALTUS USA INC. first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • WELLINGTON-ALTUS USA INC.'s Medtronic position peaked at $221K in Q4 2025.
  • 2,141 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.